Biotricity, Inc. (BTCY)
Market Cap | 17.72M |
Revenue (ttm) | 10.60M |
Net Income (ttm) | -18.11M |
Shares Out | 8.32M |
EPS (ttm) | -2.08 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 3,284 |
Open | 2.08 |
Previous Close | 2.14 |
Day's Range | 2.08 - 2.16 |
52-Week Range | 0.40 - 3.78 |
Beta | 2.35 |
Analysts | Strong Buy |
Price Target | 4.00 (+87.79%) |
Earnings Date | Nov 13, 2023 |
About BTCY
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, Cali... [Read more]
Financial Performance
In 2022, Biotricity's revenue was $9.64 million, an increase of 26.00% compared to the previous year's $7.65 million. Losses were -$19.53 million, -35.36% less than in 2021.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for BTCY stock is "Strong Buy" and the 12-month stock price forecast is $4.0.
News

Biotricity Unveils a New Digital Presence, Highlighting its Expanding Technology Portfolio and Cutting-Edge Innovations
Biotricitys New Digital Presence Reflects Commitment to Innovation in the Healthcare Space. REDWOOD CITY, CA / ACCESSWIRE / September 13, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Com...

Biotricity Achieves $14 Million Revenue Run Rate in August 2023
Corporate Impact Report concluded better patient outcomes and substantial cost savings, thus accelerating Company's sales growth REDWOOD CITY, CA / ACCESSWIRE / August 30, 2023 / Biotricity Inc. (NASD...

Biotricity Reports Strong Growth for its First Quarter Fiscal Year 2024 and Provides Financial Results and Business Updates
REDWOOD CITY, CA / ACCESSWIRE / August 15, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector...

Biotricity to Host First Quarter Fiscal Year 2024 Financial Results and Business Update Call on August 15th
REDWOOD CITY, CA / ACCESSWIRE / August 14, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector...

Biotricity Shows Continued Growth and Strength in its Fundamentals on its Path to Profitability
Company to report robust performance improvements in its operating metrics Record Q1-FY2024 recurring revenue growth Significantly higher margins on technology fees compared to blended margins Strong ...

Biotricity Is Paving The Way For Cardiac Health In The Age Of AI Technology
REDWOOD CITY, CA / ACCESSWIRE / July 26, 2023 / The integration of AI technology in healthcare has revolutionized the industry, particularly in the areas of automation, big data analytics, and optimiz...

Biotricity Expands Its Proprietary AI Model and Deepens Relationship with Amazon AWS and Google's Tensor Flow for Remote Cardiac Care Applications
Company revolutionizes cardiac preventive care with state-of-the-art AI technology that improves automation, big data analytics and optimization Biotricity expands its Amazon SageMaker feedback system...

Biotricity Regains Nasdaq Listing Compliance
REDWOOD CITY, CA / ACCESSWIRE / July 21, 2023 / Biotricity, Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today an...

Biotricity Reports Strong Start to Fiscal Year 2024
Company estimates Q1-FY24 revenue to grow YOY by over 40% Recurring technology fees, customer second-device sales, continue to trend higher REDWOOD CITY, CA / ACCESSWIRE / July 6, 2023 / Biotricity In...

Biotricity Announces Reverse Stock Split
REDWOOD CITY, CA / ACCESSWIRE / June 30, 2023 / Biotricity Holdings, Inc. ("Biotricity" or the "Company") (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today it will ...

Biotricity Reports Business Update, Financial Results for Q4 and Full Year FY23; Company Posts Robust Revenue Growth, Overall Higher Margins, with Lower SG&A Driving Clear Path to Positive Cash Flow
Company advancing toward positive cashflow likely by end of CY 2024 Accelerating product sales, and customer re-order revenue, FY23 revenue rose 26% YOY to $9.64 million on 5% lower SG&A of $17.6 mill...

Biotricity to Host Fiscal Year 2023 Financial Results and Business Update Call on June 30th
The Company recently announced reaching a record $13 million annualized revenue run rate in April 2023 REDWOOD CITY, CA / ACCESSWIRE / June 26, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or th...

Biotricity CEO Speaks to the Future of AI and its Contributions to Healthcare
Company's proprietary AI technology allows for expansion into predictive monitoring and new disease profiling The New England Journal of Medicine article cites AI and its potential for increased healt...

Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth
Corporate Impact Report concluded better patient outcomes and substantial cost savings for patients using Company's devices REDWOOD CITY, CA / ACCESSWIRE / May 16, 2023 / Biotricity Inc. (NASDAQ:BTCY)...

Biotricity's Founder & CEO Waqaas Al-Siddiq to Present at World Heart Summit May 19-21 in Geneva, Switzerland
Dr. Waqaas will address, meet with, world leaders and medical innovators on pressing challenges and solutions in global cardiovascular health, digital health and AI REDWOOD CITY, CA / ACCESSWIRE / May...

New Report Reveals Medtech Company Biotricity Decreased Patient Spending By Millions While Delivering Life-Saving Products
REDWOOD CITY, CA / ACCESSWIRE / April 21, 2023 / Biotricity Inc. (NASDAQ:BTCY), a medical technology company committed to improving healthcare by developing solutions that aid in chronic disease preve...

Biotricity Reaches $12M Revenue Run Rate in March with Promising Future Growth Ahead
REDWOOD CITY, CA / ACCESSWIRE / April 19, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnostic and consumer healthcare technology company, today reported ...

Leading Medical Biometric Firm Biotricity Releases First Corporate Impact Report
"Inducing Better Patient Outcomes, Substantial Cost Savings" REDWOOD CITY, CA / ACCESSWIRE / April 11, 2023 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a leading medical diagnost...

Medical Biometric Firm Biotricity Reshaping Market Through Pioneering Innovation
Highlights Several Major Operating Milestones Since FY22 REDWOOD CITY, CA / ACCESSWIRE / March 7, 2023 / Biotricity, Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consum...

Biotricity Reports Financial Results for Fiscal 2023 Third Quarter
Revenue Up 27.4% YOY Enviable 98% Customer Retention Rate Drives Subscription Recurring Rev Growth Two Major Distribution Agreements Implemented Net Loss Narrowed by One Third as Company Targets Posit...

Biotricity To Host Fiscal 2023 Third Quarter Financial Results Call on February 14th at 4:30pm ET
REDWOOD CITY, CA / ACCESSWIRE / February 9, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it wi...

Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
REDWOOD CITY, CA / ACCESSWIRE / February 3, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is excited to announc...

Biotricity Signs Distribution Agreement With Top 5 Distributor for its Cardiac Monitoring Solutions
REDWOOD CITY, CA / ACCESSWIRE / January 26, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced it ha...

Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET
REDWOOD CITY, CA / ACCESSWIRE / January 23, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that ...

Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023
REDWOOD CITY, CA / ACCESSWIRE / January 17, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced it has sign...